查看更多>>摘要:Objective: To systematically evaluate the efficacy and safety of traditional Chinese medicine combined with hydroxychloroquine sulfate in the treatment of Sjogren's Syndrome(SS). Methods: Two researchers searched the databases of Chinese National Knowledge Infrastructure(CNKI), Wanfang Database,Weipu Database, Chinese Biomedical Literature Database, PubMed Database, Web of science Database and The Cochrane Library Database(the retrieval period is from the establishment of the database to October 2020) and screened the literatures independently.The data were extracted for bias risk assessment, and then meta-analysis was performed using Revman 5.3 software. Results: A total of 19 articles involving 1185 patients were included, including 617 cases in the treatment group and 568 cases in the control group. Combined data analysis showed that the total effective rate of traditional Chinese medicine combined with hydroxychloroquine sulfate in the treatment of Sjogren's syndrome was significantly higher than that of hydroxychloroquine sulfate alone [R R=1.34,95%CI(1.24,1.44),P<0.00001].The improvement of salivary gland[SMD=0.66,95%CI (0.47,0.85),P<0.00001], tear secretion function [MD=2.56,95%CI(1.29,3.83),P<0.0001] and reducing CRP[MD=-3.53,95%CI(-3.93,-3.14),P<0.00001], ESR [MD=-5.80,95%CI(-8.48,-3.13),P<0.00001]were better than those of the control group. However, there was no significant difference in the reduction of IgG and the incidence of adverse reactions between the two groups. Conclusion: Traditional Chinese medicine combined with hydroxychloroquine sulfate in the treatment of SS is superior to the control group in total effective rate, improvement of salivary gland and tear secretion function, and reduction of CRP and ESR, and we didn't see the significantly increase on the adverse event.However, due to the small sample size and low quality of the included studies, the conclusion needs to be verified by larger sample and higher quality randomized controlled trials.